Patents by Inventor R. Curtis Haltiwanger

R. Curtis Haltiwanger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Forms of a multicyclic compound
    Patent number: 8633314
    Abstract: The present invention provides alternative forms of Compound I, processes to reproducibly make them and methods of treating patients using them.
    Type: Grant
    Filed: February 24, 2012
    Date of Patent: January 21, 2014
    Assignee: Cephalon, Inc.
    Inventors: Stephen Bierlmaier, Michael Christie, R. Scott Field, R. Curtis Haltiwanger, Linli He, Martin J. Jacobs, Michael Kress, Robert E. McKean, Dale R. Mowrey, Joseph Petraitis, Mehran Yazdanian, Veronique Courvoisier
  • Forms of a fused pyrrolocarbazole compound
    Patent number: 8513272
    Abstract: Alternative chemical and/or solid state forms of Compound I, processes to reproducibly make them and methods of treating patients using them.
    Type: Grant
    Filed: May 11, 2011
    Date of Patent: August 20, 2013
    Assignee: Cephalon, Inc.
    Inventors: Stephen Bierlmaier, Raymond Scott Field, R. Curtis Haltiwanger, Martin J. Jacobs, Robert E. McKean, Mehran Yazdanian, Veronique Courvoisier
  • Novel forms of a multicyclic compound
    Publication number: 20120214998
    Abstract: The present invention provides alternative forms of Compound I, processes to reproducibly make them and methods of treating patients using them.
    Type: Application
    Filed: February 24, 2012
    Publication date: August 23, 2012
    Applicant: Cephalon, Inc.
    Inventors: Stephen Bierlmaier, Michael Christie, Laurent Courvoisier, Veronique Courvoisier, R. Scott Field, R. Curtis Haltiwanger, Linli He, Martin J. Jacobs, Michael Kress, Robert E. McKean, Dale R. Mowrey, Joseph Petraitis, Mehran Yazdanian
  • Forms of bendamustine free base
    Patent number: 8076366
    Abstract: Novel polymorphic forms of bendamustine free base are described, including amorphous bendamustine free base, six anhydrous crystalline forms, four hydrate forms, and five solvate forms, with methods of their preparation and use also being described.
    Type: Grant
    Filed: January 14, 2010
    Date of Patent: December 13, 2011
    Assignee: Cephalon, Inc.
    Inventors: Laurent D. Courvoisier, Mark Eddleston, R. Curtis Haltiwanger, Robert E. McKean
  • Novel Forms of a Fused Pyrrolocarbazole Compound
    Publication number: 20110230508
    Abstract: Alternative chemical and/or solid state forms of Compound I, processes to reproducibly make them and methods of treating patients using them.
    Type: Application
    Filed: May 11, 2011
    Publication date: September 22, 2011
    Applicant: CEPHALON, INC.
    Inventors: Stephen Bierlmaier, Laurent Courvoisier, Raymond Scott Field, R. Curtis Haltiwanger, Martin J. Jacobs, Robert E. McKean, Mehran Yazdanian, Veronique Courvoisier
  • Novel Forms of Bendamustine Free Base
    Publication number: 20100210701
    Abstract: Novel polymorphic forms of bendamustine free base are described, including amorphous bendamustine free base, six anhydrous crystalline forms, four hydrate forms, and five solvate forms, with methods of their preparation and use also being described.
    Type: Application
    Filed: January 14, 2010
    Publication date: August 19, 2010
    Applicant: CEPHALON, INC.
    Inventors: Laurent D. Courvoisier, Mark Eddleston, R. Curtis Haltiwanger, Robert E. McKean
  • Novel crystalline forms of Lestaurtinib
    Publication number: 20090227650
    Abstract: Novel crystalline forms of lestaurtinib are described, including six co-crystal forms, nineteen solvate forms, three anhydrate forms and one hemihydrate form. Methods of their preparation and use are also described.
    Type: Application
    Filed: January 16, 2009
    Publication date: September 10, 2009
    Applicant: Cephalon, Inc.
    Inventors: Stephen Bierlmaier, Laurent Courvoisier, Raymond Scott Field, R.Curtis Haltiwanger, Martin J. Jacobs, Robert E. McKean, Mehran Yazdanian